Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Oral meds good for controlling Type II diabetes in children

17.08.2005


Oral medications may control symptoms of Type II diabetes in children just as well as insulin injections, a new study reports.



According to the medical records of 26 children diagnosed with the disease, oral medications reduced levels of a compound in the blood called hemoglobin A1C by an average of 2 percentage points.

A 2-percentage-point reduction is enough to decrease serious health risks and symptoms associated with Type II diabetes, said Milap Nahata, the study’s principal investigator and a professor of pharmacy and pediatrics at Ohio State University .


High blood sugar levels leave a diabetic vulnerable to developing heart and kidney disease and vision problems; symptoms include frequent urination and excessive thirst. Diabetics normally show high levels of hemoglobin A1C, which is a marker for blood sugar levels.

“This is the first study to show that oral medications may decrease these levels in children,” Nahata said.

The researchers wanted to compare the effectiveness of injected insulin to oral medications in lowering levels of this hemoglobin marker in children. Clear guidelines on the best treatments for children with Type II, or insulin-resistant, diabetes, have yet to be established, said Nahata.

“It’s only been within the last 20 years that we’ve seen large numbers of children developing this disease,” he said. “And most oral medications typically prescribed to children with the illness have never been compared to one another or to insulin.”

A common side effect of insulin is weight gain, which often discourages medication compliance among teenagers, Nahata said.

The results appear in a recent issue of the journal Pharmacotherapy.

In Type II diabetes the body’s cells don’t respond to insulin, the hormone that helps the body regulate blood sugar levels.

The researchers gathered five years’ worth of hemoglobin A1C values, medication and symptom data from the children’s medical records. All of the children lived in central Ohio . The average age was 15 for boys and 14 for girls.

Medications prescribed included insulin for some children and the oral drugs metformin and sulfonylurea. Some children took a combination of the drugs. While insulin and metformin are the only two drugs approved by the Food and Drug Administration for treating children with Type II diabetes, pediatricians have the authority to prescribe a different drug if they think it can do a better job of controlling a patient’s disease. It’s fairly common practice for doctors to do this, too.

“Fully 80 percent of the drugs on the market have never been studied adequately for use in children,” Nahata said.

In the study, the 14 children who were treated with insulin achieved the greatest reduction of the hemoglobin compound – from an average of 11.1 percent to 8.1 percent. Some of these children were also prescribed an oral drug.

“But the children treated with insulin also had the highest values to begin with,” Nahata said.

While normal hemoglobin A1C values range from 4 to 6 percent, reaching a value of 7 percent is considered a success for diabetics. But even reducing that value to 8 percent can cause a notable reduction in symptoms and risks associated with Type II diabetes.

According to the American Diabetes Association, the average diabetic has a hemoglobin A1C value of about 9 percent. Untreated, these levels can leave a person at serious risk for developing other health problems.

Values of the compound decreased from an average of 10.6 to 8 percent in the other 12 children who were prescribed the oral drugs only – a reduction comparable to those getting injections.

Half (13) of the children included in the study were able to lower the values of the hemoglobin compound to 7 percent or less. Another three children reduced their values to between 7 and 8 percent.

Type II diabetes is a disease that traditionally strikes overweight and obese adults. But more and more children have developed this disease due to childhood obesity rates nearly doubling in the past 20 years.

“Type II diabetes in children was almost unheard of when I started in pharmacy 30 years ago,” Nahata said. “It was supposed to be a disease that adults developed.”

Children are usually much more prone to developing Type I, or insulin-dependent, diabetes, a disease in which the pancreas does not produce enough insulin.

While Nahata says the results of this small study are interesting and may apply to the larger population, additional studies that include more patients are needed to compare the effectiveness of the drugs to each other for controlling the illness and its complications.

“We don’t yet know what the ideal drug or drug combination is for treating children with Type II diabetes,” Nahata said.

Children are at risk of developing Type II diabetes if

  • their body mass index (BMI, a measurement that relates weight to height) is above the 85th percentile for their age and sex;
  • they weigh 120 percent of their ideal weight;
  • have a parent or grandparent who also has the disease;
  • are African-American, Native American, Mexican American and Asian or Pacific Islander; and
  • show signs of insulin resistance.

Nahata conducted the study with Ohio State colleagues Jeffrey Striet and John Germak and with Sandra Benavides, who is with the University of Texas’ Pan American Cooperative Pharmacy Program.

Milap Nahata | EurekAlert!
Further information:
http://www.osu.edu

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>